Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QX3G
|
|||
| Drug Name |
PMID29671355-Compound-22
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH BRESLOW, Ronald MARKS, Paul, A
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H18N2O4
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)N(CCO)C(=O)CC2=CC=C(C=C2)C(=O)NO
|
|||
| InChI |
1S/C17H18N2O4/c20-11-10-19(15-4-2-1-3-5-15)16(21)12-13-6-8-14(9-7-13)17(22)18-23/h1-9,20,23H,10-12H2,(H,18,22)
|
|||
| InChIKey |
RFAZNTABYJYOAR-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.